(R)-N-((S)-4-(2-amino-2-oxoethyl)-3-oxo-2,3,4,5-tetrahydro-1H-naphtho[2,1-c]azepin-2-yl)-2-((S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanamido)-5-guanidinopentanamide

ID: ALA4165323

PubChem CID: 145963745

Max Phase: Preclinical

Molecular Formula: C33H42N8O5

Molecular Weight: 630.75

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H]1Cc2c(ccc3ccccc23)CN(CC(N)=O)C1=O

Standard InChI:  InChI=1S/C33H42N8O5/c1-18-12-22(42)13-19(2)24(18)14-26(34)30(44)39-27(8-5-11-38-33(36)37)31(45)40-28-15-25-21(16-41(32(28)46)17-29(35)43)10-9-20-6-3-4-7-23(20)25/h3-4,6-7,9-10,12-13,26-28,42H,5,8,11,14-17,34H2,1-2H3,(H2,35,43)(H,39,44)(H,40,45)(H4,36,37,38)/t26-,27+,28-/m0/s1

Standard InChI Key:  VRLMPUXFAPNKKK-IARZGTGTSA-N

Molfile:  

     RDKit          2D

 46 49  0  0  0  0  0  0  0  0999 V2000
   36.7436   -5.0786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5282   -4.2873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5026   -5.4040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2292   -5.0129    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.3743   -4.2009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2036   -5.4892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9113   -5.0806    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.4958   -5.0806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2036   -6.3064    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.6190   -5.4892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3267   -5.0806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0344   -5.4892    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.3267   -4.2634    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.6190   -6.3064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3267   -6.7150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3267   -7.5322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0344   -7.9408    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.0344   -8.7580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7421   -9.1666    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.3267   -9.1666    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.0098   -3.6216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8352   -3.5794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2097   -2.8447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7597   -2.1516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5388   -6.2203    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.8910   -5.4923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6371   -5.1589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2989   -5.6383    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.7214   -4.3461    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.4958   -4.2634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7881   -5.4892    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.7881   -3.8548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7911   -3.0366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0842   -2.6281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3756   -3.0367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3782   -3.8581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0856   -4.2629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0883   -5.0801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4997   -2.6294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6673   -2.6291    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.5607   -2.9331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9364   -2.1959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4859   -1.5041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6600   -1.5483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2864   -2.2901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7391   -2.9789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2 21  1  0
  1  3  1  0
  3  4  1  0
 22  5  1  0
  4  5  1  0
  6  7  1  0
  6  8  1  0
  6  9  2  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 10 14  1  1
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
  1 12  1  1
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 42  1  0
 41 21  1  0
  3 25  2  0
  4 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
  8 30  1  1
  8 31  1  0
 30 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 32  1  0
 37 38  1  0
 33 39  1  0
 35 40  1  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 46  1  0
 46 41  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4165323

    ---

Associated Targets(non-human)

Oprd1 Delta opioid receptor (3127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Mu opioid receptor (3620 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprm1 Mu opioid receptor (1674 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 630.75Molecular Weight (Monoisotopic): 630.3278AlogP: 0.34#Rotatable Bonds: 12
Polar Surface Area: 229.75Molecular Species: BASEHBA: 7HBD: 8
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.74CX Basic pKa: 11.80CX LogP: 0.08CX LogD: -2.21
Aromatic Rings: 3Heavy Atoms: 46QED Weighted: 0.08Np Likeness Score: 0.12

References

1. Van der Poorten O, Van Den Hauwe R, Eiselt E, Betti C, Guillemyn K, Chung NN, Hallé F, Bihel F, Schiller PW, Tourwé D, Sarret P, Gendron L, Ballet S..  (2017)  χ-Space Screening of Dermorphin-Based Tetrapeptides through Use of Constrained Arylazepinone and Quinolinone Scaffolds.,  (11): [PMID:29152051] [10.1021/acsmedchemlett.7b00347]

Source